Investment
Features
FeesSafety
Academy
More
Pluang+

Audi launches Q9 SUV to boost U.S. sales amid 17% decline in 2026

Market News
28 Jul 2026
CNBC
View Source
Neutral
pluang ai news

Audi introduced the Q9, a three-row luxury SUV starting at $89,095, targeting the U.S. market where its sales have dropped 17% in 2026. The Q9 and its sportier SQ9 variant offer powerful engines, advanced tech like ChatGPT voice assistant, and luxury features to compete with rivals like Mercedes and BMW. Audi aims to reverse its sales decline by focusing on SUVs, which dominate the premium market, but faces challenges from tariffs and lack of U.S. manufacturing. The new SUVs could help Audi regain ground, though tariffs remain a key hurdle.

More News

AGC Biologics secures multi-year, multi-million dollar commercial production deal for new Yokohama biopharma site.

AGC Biologics secures multi-year, multi-million dollar commercial production deal for new Yokohama biopharma site.

AGC Biologics has signed a multi-year commercial manufacturing agreement with a major pharmaceutical company for its new Yokohama facility, locking in half of the mammalian cell production capacity. The deal, worth hundreds of millions of dollars, co...

Company Fundamentals
Bullish
3 hours ago
AGC Biologics secures multi-year commercial manufacturing deal worth hundreds of millions for new Yokohama site.

AGC Biologics secures multi-year commercial manufacturing deal worth hundreds of millions for new Yokohama site.

AGC Biologics has signed a multi-year commercial manufacturing contract valued at hundreds of millions of dollars with a major biopharma company for its new Yokohama facility. The contract covers production of five biopharmaceutical programs, securin...

Company Fundamentals
Bullish
3 hours ago
AGC Biologics signs multi-year commercial production deal worth hundreds of millions for new Yokohama facility.

AGC Biologics signs multi-year commercial production deal worth hundreds of millions for new Yokohama facility.

AGC Biologics has secured a long-term commercial manufacturing contract with a global biopharma company for its new Yokohama facility, expected to generate hundreds of millions of dollars. The contract covers production of five biopharmaceutical prod...

Company Fundamentals
Bullish
3 hours ago
Seagate surges on Q4 earnings beat and AI-driven data storage demand

Seagate surges on Q4 earnings beat and AI-driven data storage demand

Seagate Technology reported strong Q4 2026 results, beating earnings per share estimates with $5.71 and revenue of $3.63 billion, driven by high demand for data storage from the AI sector. The company showed solid financial health with a low debt-to-...

Company Fundamentals
Bullish
4 hours ago
Audiera (BEAT) drops 24%, breaks $3 support amid heavy selling pressure and market outflows.

Audiera (BEAT) drops 24%, breaks $3 support amid heavy selling pressure and market outflows.

Audiera (BEAT) fell sharply by 24.29%, breaking below the $3 support level to a low of $2.4 before slightly recovering to around $2.76. The drop followed increased selling pressure with significant outflows in both futures and spot markets, indicatin...

Technical Signals
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App